Programmed cell death, apoptosis and nervous system

Neurologia Croatica

Volumn 46, Issue 1-2, 1997, Pages 3-18

  Zurak, N ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Antiapoptotic agents; Apoptosis; Neural disease; Programmed cell death

Indexed keywords

AMANTADINE; ANDROGEN; ANTICONVULSIVE AGENT; CALPASTATIN; CYSTEINE PROTEINASE INHIBITOR; DNA FRAGMENT; ESTROGEN; FREE RADICAL; GLYCERYL TRINITRATE; GLYCOPROTEIN GP 39; GROWTH FACTOR; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; NEUROSTEROID; PROTEIN BCL 2; TUMOR PROMOTER; VIRUS VECTOR; ZINC;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CLINICAL TRIAL; DEGENERATIVE DISEASE; HUMAN; NERVE CELL NECROSIS; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY;

EID: 0030726119     PISSN: 03538842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Adams JD, Mukherjee SK, Klaidman LK, Chang ML, Yasharel R. Apoptosis and oxidative stress in the aging brain. ANYAS 1996; 86: 135-151.
2. Albin RT. Selective neurodegeneration in Huntington's disease. Ann Neurol 1995; 38: 835-836.
3. Altman J. Programmed cell death: the paths to suicide. Trends Pharmacol Sci 1992; 15; 278-280.
4. Anderson AJ, Su JH, Cotmari CW. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 1996; 16; 1710-19.
5. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990; 136: 593-608.
6. Bosman GJCGM, De Grip WJ. Neuronal aging and Alzheimer's disease. Arch Cell Aging Gerontol 1996; 1: 157-168.
7. Bosman GJCGM. Apoptosis and Alzheimer's disease. Alzheimer's disease 1997; 215: 251-252.
8. Borchelt DR, Lee MK Slunt HH et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994; 91: 18292-8296.
9. Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J. Pattern of brain destruction in Parkinson's and Alzheimer's disease. J Neural Transm 1996b; 103: 455-490.
10. Bredesen D. Neural apoptosis. Ann Neurol 1996; 38: 839-851.
11. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974; 77:71-94.
12. Brown RH. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687-692.
13. Burek MJ, Oppenheim RW. Programmed cell death in the developing nervous system. Brain Pathology 1996; 6: 427-446.
14. Caskey CT, Pizzuti A, Fu Y-H, Fenwick RG, Jr, Nelson DL. Triplet repeat mutations in human disease. Science 1992; 256: 784-789.
15. Charriaut-Marlange C, Aggoun-Zouaoui D, Represa A, Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity. Trends Neurosci 1996; 19/3: 109-114.
16. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 1997; 275: 1122-1132.
17. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-634.
18. Choi DW. Excitotoxic cell death. J Neurobiol 1992; 23: 1261-1276.
19. Choi DW. Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 1994; 100: 47-51.
20. Clutterbuck RE, Price DL, Koliatsos VE. Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system. Proc Natl Acad Sci USA 1993; 90: 2222-2226.
21. Cotman CW, SU JH. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathology 1996; 6: 493-506.
22. Driscoll M. Cell death in Caenorhabditis elegans: molecular insights into a mechanisms conserved between nematodes and mammals. Brain Pathology 1996; 6: 411-425.
23. Ellis RE, Horvitz HR. Genetic control of programmed cell death in the nematode C.elegans. Cell 1986; 44: 817-829.
24. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol 1991; 7: 663-698.
25. Gage FH, Kawaja MD, Fisher IJ. Genetically modified cells: applications for intracerebral grafting. Trends Neurosci 1991; 14: 328-333.
26. Gerlach M, Riederer P, Youdim MBH. Molecular mechanisms for neurodegeneration. In: Battistin L, Scarlati G, Caraceni T, Ruggieri S, eds. Advances in Neurology. Philadelphia: Lipincott-Raven, 1996, 69: 177-194.
27. Greenlund LJ, Deckwerth TL, Johnson EM, Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995; 14: 303-315.
28. Golstein P. Controlling cell death. Science 1997; 275: 1081-1082.
29. Hefti F, Michel PP, Knusel B. Neurotrophic factors and Parkinson's disease. Adv Neurol 1990; 53: 123-127.
30. Hefti F., Schneider LS. Nerve growth factor and Alzheimer's disease. Clin Neuropharmacol 1991; 14: 562-66.
31. Hunter J. The role of animal models in assesing therapeutic efficacy of novel neuroprotective agents. In: Delaying dysfunction and death of neurones and disintegration of synapses-prospects for developing treatment strategies. London: Henry Stewart Conference Studies, 1996; 169-178.
32. Johnson EM, Jr, Deckwerth TL. Molecular mechanism of devel neuronal death. Annu Rev Neurosci 1993: 16; 31-46.
33. Johnson EM, Deckwerth TL, Desmukh M. Neuronal death in developmental models: possible implications in neuropathology. Brain Pathology 1996; 6: 397-409.
34. Junck L, Fink K. Machado-Joseph disease and SCA3: the genotype meets the phenotypes. Neurology 1996; 46: 4-8.
35. Kerr JFR. Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue genetics. Br J Cancer 1972; 26: 239.
36. Koliatsos VE, Price DL. Axotomy as an experimental model of neuronal injury and cell death. Brain Pathology 1996; 6: 447-465.
37. Lassmann H, Bancher C, Breitschopf H et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995; 89: 35-41.
38. Linnik MD. Role of apoptosis in acute neurodegenerative disorders. Restor Neurol Neurosci 1996; 9: 219-225.
39. Lipton SA. Calcium channel antagonists in the prevention of neurotoxicity. Adv Pharmacol 1991; 22: 2002-2008.
40. Lipton SA. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 1992; 42: 1403-1405.
41. Lipton SA. Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states of nitric oxide. Trends Neurosci 1993; 16: 527-532.
42. Lipton SA, Rosenberg PA Mechanisms of disease: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622.
43. Lipton SA. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathology 1996; 6: 507-517.
44. Maysinger D, Piccardo P, Filipović-Grčić J, Cuello AC. Microencapsulation and the grafting of genetically transformed cells as therapeutic strategies to rescue degenerating neurons of the CNS. Neurosciences 1995; 6: 15-33.
45. Mc Geer PL, Itagaki S, Boyes BE, Mc Geer EG. Rate of cell death in Parkinsonism indicates active neuropathological process. Ann Neurol 1988; 24: 574-576.
46. Meakin SO, Shooter EM. The nerve rowth factor family of receptors. Trends Neurosci 1992; 15: 323-331.
47. Neff NT. K-252a compounds as modulatory of neurotrophic activity, in: Delaying dysfunction and death of neurones and disintegration of synapses-prospects for developing treatment strategies. London: Henry Stewart Conference Studies, 1996: 9-13.
48. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 1993; 56: 39-44.
49. O'Neill MJ. The role of excitotoxicity in mediating cell death in the nervous system. Delaying dysfunction and death of neurones and disintegration of synapses-prospects for developing treatment strategies. London: Henry Stewart Conference Studies, 1996; 13-25.
50. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14: 453-501.
51. Pellegrini JW, Lipton SA. Delayed administration of memantine prevents N-methyl-D-aspartate receptor mediated neurotoxicity. Ann Neurol 1993; 33: 403-407.
52. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995; 146: 1121-1130.
53. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995; 15: 3775-3787.
54. Price DL, Koo EH, Sisodia SS et al. Neuronal responses to injury and aging:lessons from animal models. Prog Brain Res 1990; 86: 297-308.
55. Price DL, Becher MW, Wong PC, Borchelt DR, Lee MK, Sisodia SS. Inherited neurodegenerative diseases and transgenic models. Brain Pathology 1996; 6: 467-480.
56. Rathan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis in embrionic cortical neurons. J Neurochem 1994; 62: 376-379.
57. Ross ME. Cell division and the nervous system: regulation the cycle from neuronal differentation to death. Trends Neurosci 1996; 19/2: 62-68.
58. Schaetzl HM. Neurotrophic factors: ready to go? Trends Neurosci 1995; 18/11:463-64.
59. Schwartz LM, Smith SW, Jones MEE, Osborne BA. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 1993; 90: 980-984.
60. Shivers B. Targeting ICE family members: opportunity to inhibit necrosis or apoptosis in neurodegenerative diseases. Delaying dysfunction and death of neurones and disintegration of synapses-prospects for developing treatment strategies. London: 1996: Henry Stewart Conference Studies, 37-66.
61. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE, Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995; 133: 225-230.
62. Steinhaeuser C, Gallo V. News on glutamate receptors in glial cells. Trends Neurosci 1996; 19/8: 339-345.
63. Stern G. Parkinson's disease: The apoptotic hypothesis. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S, eds. Advances in Neurology. Philadelphia: Lippincott-Raven 1996; 69: 101-107.
64. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 1994; 5: 2529-2533.
65. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
66. Verkhratsky A, Kettenmann H. Calcium signalling in glial cells. Trends Neurosci 1996; 19/8: 346-352.
67. Vogt O. Der Begriff der Pathoklise. J Psychol Neurol 1925; 31: 245-255.
68. Wyllie AH, Kerr JRF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cyt 1980; 68: 251-306.